{"id":"W2979480540","doi":"10.1016/j.clinthera.2019.09.008","title":"Cost-effectiveness of Osimertinib as a Second-line Treatment in Patients With EGFR-mutated Advanced Non–Small Cell Lung Cancer in China","year":2019,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"China Medical Board","keywords":"Medicine; Osimertinib; Docetaxel; T790M; Oncology; Pemetrexed; Lung cancer; Internal medicine; Epidermal growth factor receptor; Cost effectiveness; Gemcitabine; Cancer; Chemotherapy; Erlotinib; Gefitinib; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006558929,0.0003172588,0.0006984699,0.0007027324,0.0003226502,0.0007058376,0.0004572795,0.000443018,0.001317665],"category_scores_gemma":[0.001294735,0.0001389372,0.001562712,0.001059372,0.0003510858,0.0005021043,0.0005366348,0.0004876841,0.0000480644],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005730388,"about_ca_system_score_gemma":0.005563015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05823388,"about_ca_topic_score_gemma":0.08406369,"domain_scores_codex":[0.9994363,0.000168663,0.00005351127,0.00005892564,0.00009479723,0.0001877223],"domain_scores_gemma":[0.999281,0.00009624187,0.0002207958,0.00001395021,0.00006758603,0.0003204231],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01246767,0.001043324,0.8791748,0.000587865,0.001634991,0.0008353087,0.0001970341,0.008576423,0.001072419,0.0009067415,0.003588343,0.08991508],"study_design_scores_gemma":[0.001556988,0.002958632,0.9773522,0.0001201904,0.001953109,0.0003888574,0.0005109202,0.01248665,0.0002499502,0.0003735292,0.00201196,0.00003708683],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995902,0.002413504,0.00004098723,0.0006483835,0.00002816232,0.00002544724,0.0003042502,0.000003696968,0.0006336604],"genre_scores_gemma":[0.9986785,0.0005496693,0.00004386666,0.0001445174,0.00002589503,0.00001494494,0.0003345621,0.000001065695,0.0002068546],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05823388,"threshold_uncertainty_score":0.1157898,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03739784824940182,"score_gpt":0.4140337343373992,"score_spread":0.3766358860879974,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}